Poseida Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of PSTX for the last quarter is 28.14 M USD, and it's 12.59% higher compared to the previous quarter. The net income of Q1 24 is -24.27 M USD.